Emergent BioSolutions (EBS) - Cekelan dhuwit saben saham

Simbol lan logo merek Emergent Bio (EBS)

This chart of liquid assets per share visualizes the results of the restructuring and the strategic shift of Emergent BioSolutions (EBS) toward high-margin government contracts. The value of 3.46 confirms the current level of solvency. Stability is ensured by monopoly supplies of antidotes to US reserves, while supply chain management efficiency is achieved through the outsourcing of logistics and IT infrastructure.

emergentbiosolutions.com - Dhuwit awis saben siji saham EBS (periode 04.07.2022 - 20.11.2026)

Rincian metrik komprehensif lan analitis Emergent BioSolutions Inc. (EBS)

- kuotasi saiki lan rata-rata prakiraan nilai:
- data dhuwit lan arus kas:
Ringkesan analisis perusahaan:Emergent BioSolutions
Barang unggulan emergentbiosolutions.com

For an investor, assessing the liquidity of Emergent BioSolutions (EBS) is critical when analyzing the resilience of a complex vaccine distribution system and the maintenance of strict cold chain requirements. This cash per share metric is calculated by dividing total net cash by the number of outstanding shares, determining the actual capital value available to cover operational risks or expand biopharmaceutical production.